(Q42652797)

English

Biodistribution and dosimetry results from a phase III prospectively randomized controlled trial of Zevalin radioimmunotherapy for low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma.

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11418315 AND SRC:MED&resulttype=core&format=json

8 November 2019

Biodistribution and dosimetry results from a phase III prospectively randomized controlled trial of Zevalin radioimmunotherapy for low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11418315 AND SRC:MED&resulttype=core&format=json

8 November 2019

phase III clinical trial

0 references

Nancy L Bartlett

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11418315 AND SRC:MED&resulttype=core&format=json

8 November 2019

author name string

G A Wiseman

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11418315 AND SRC:MED&resulttype=core&format=json

8 November 2019

C A White

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11418315 AND SRC:MED&resulttype=core&format=json

8 November 2019

R B Sparks

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11418315 AND SRC:MED&resulttype=core&format=json

8 November 2019

W D Erwin

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11418315 AND SRC:MED&resulttype=core&format=json

8 November 2019

D A Podoloff

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11418315 AND SRC:MED&resulttype=core&format=json

8 November 2019

D Lamonica

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11418315 AND SRC:MED&resulttype=core&format=json

8 November 2019

J A Parker

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11418315 AND SRC:MED&resulttype=core&format=json

8 November 2019

W L Dunn

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11418315 AND SRC:MED&resulttype=core&format=json

8 November 2019

S M Spies

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11418315 AND SRC:MED&resulttype=core&format=json

8 November 2019

R Belanger

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11418315 AND SRC:MED&resulttype=core&format=json

8 November 2019

T E Witzig

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11418315 AND SRC:MED&resulttype=core&format=json

8 November 2019

B R Leigh

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11418315 AND SRC:MED&resulttype=core&format=json

8 November 2019

publication date

1 July 2001

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11418315 AND SRC:MED&resulttype=core&format=json

8 November 2019

Critical Reviews in Oncology Hematology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11418315 AND SRC:MED&resulttype=core&format=json

8 November 2019

39

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11418315 AND SRC:MED&resulttype=core&format=json

8 November 2019

1-2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11418315 AND SRC:MED&resulttype=core&format=json

8 November 2019

181-194

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11418315 AND SRC:MED&resulttype=core&format=json

8 November 2019

Iodine-131-anti-B1 radioimmunotherapy for B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1016/S1040-8428(01)00107-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I/II trial of IDEC-Y2B8 radioimmunotherapy for treatment of relapsed or refractory CD20( ) B-cell non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016/S1040-8428(01)00107-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Quantification of the distribution of 111In-labelled platelets in organs.

1 reference

https://api.crossref.org/works/10.1016/S1040-8428(01)00107-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I/II 90Y-Zevalin (yttrium-90 ibritumomab tiuxetan, IDEC-Y2B8) radioimmunotherapy dosimetry results in relapsed or refractory non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016/S1040-8428(01)00107-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Multicenter phase II study of iodine-131 tositumomab for chemotherapy-relapsed/refractory low-grade and transformed low-grade B-cell non-Hodgkin's lymphomas

1 reference

https://api.crossref.org/works/10.1016/S1040-8428(01)00107-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Association of serum Rituximab (IDEC-C2B8) concentration and anti-tumor response in the treatment of recurrent low-grade or follicular non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016/S1040-8428(01)00107-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1040-8428(01)00107-X

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11418315 AND SRC:MED&resulttype=core&format=json

8 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11418315 AND SRC:MED&resulttype=core&format=json

8 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42652797&oldid=1577529445"